drugset / Trial / NCT02654041

Study of Induction of Hypothyroxinemia Adjunct to Conventional Therapies in GBM Patients

NCT02654041

NaSingle-groupOpen-labelSupportive care

Summary

The objective of the study is to assess the safety and efficacy of treatment with hypothyroxinemia adjunct to conventional therapies in GBM patients.

Timeline

Start
2016-03
Primary completion
2017-06
Completion
2017-06

Drugs

EvaluationDrugModalityDoseRoute
Subject Liothyronine Small molecule Oral
Subject Methimazole Small molecule Oral

Indications